At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
TOI The Oncology Institute
Trading 03-13 09:58:34 EDT
3.24
+0.62
+23.66%
High3.39Low2.93Vol3.98M
Open3.16D1 Closing2.62Amplitude17.56%
Mkt Cap318.76MTradable Cap267.10MTotal Shares98.38M
T/O12.84MT/O Rate4.83%Tradable Shares82.44M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

B. Riley Adjusts Price Target on Oncology Institute to $8 From $6, Maintains Buy Rating
MT Newswires Live  ·  19:59
B. Riley Adjusts Price Target on Oncology Institute to $8 From $6, Maintains Buy Rating
Oncology Institute Price Target Maintained With a $5.00/Share by Needham
Dow Jones  ·  19:31
Oncology Institute Price Target Maintained With a $5.00/Share by Needham
Why Oncology Institute Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Benzinga_recent_news  ·  17:41
Why Oncology Institute Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Oncology Institute Q4 Loss Narrows, Revenue Rises
MT Newswires Live  ·  05:58
Oncology Institute Q4 Loss Narrows, Revenue Rises
Tempus AI study finds 12% of community oncology patients gain actionable results from advanced genomic profiling features
Reuters  ·  03-11 20:31
Tempus AI study finds 12% of community oncology patients gain actionable results from advanced genomic profiling features
Oncology Institute Inc expected to post a loss of 9 cents a share - Earnings Preview
Reuters  ·  03-11 04:17
Oncology Institute Inc expected to post a loss of 9 cents a share - Earnings Preview
Analysts Have Conflicting Sentiments on These Healthcare Companies: Roche Holding AG (OtherRHHVF), Incyte (INCY) and Oncology Institute (TOI)
TIPRANKS  ·  03-09
Analysts Have Conflicting Sentiments on These Healthcare Companies: Roche Holding AG (OtherRHHVF), Incyte (INCY) and Oncology Institute (TOI)
Oncology Institute Price Target Maintained With a $7.00/Share by BTIG
Dow Jones  ·  03-09
Oncology Institute Price Target Maintained With a $7.00/Share by BTIG
The Oncology Institute Inc. published an update to their financial calendar
Reuters  ·  02-26
The Oncology Institute Inc. published an update to their financial calendar
The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March
Reuters  ·  02-25
The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March
Oncology Institute appoints Kim Tzoumakas to board of directors
TIPRANKS  ·  02-23
Oncology Institute appoints Kim Tzoumakas to board of directors
The Oncology Institute Names Kim Tzoumakas to Board of Directors
Reuters  ·  02-23
The Oncology Institute Names Kim Tzoumakas to Board of Directors
the Oncology Institute Appoints Kim Tzoumakas to Board of Directors
THOMSON REUTERS  ·  02-23
the Oncology Institute Appoints Kim Tzoumakas to Board of Directors
The Oncology Institute Inc. Files Initial Statement of Beneficial Ownership for Director Mark Stolper
Reuters  ·  01-13
The Oncology Institute Inc. Files Initial Statement of Beneficial Ownership for Director Mark Stolper
The Oncology Institute Targets 20% Annual Revenue Growth Through 2028
Reuters  ·  01-12
The Oncology Institute Targets 20% Annual Revenue Growth Through 2028
the Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook
THOMSON REUTERS  ·  01-12
the Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook
Oncology Institute Inc: Looking Beyond 2026, Co Is Well Positioned for Continued Expansion
THOMSON REUTERS  ·  01-12
Oncology Institute Inc: Looking Beyond 2026, Co Is Well Positioned for Continued Expansion
Press Release: The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook
Dow Jones  ·  01-12
Press Release: The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook
Is Oncology Institute’s (TOI) New Tech‑Heavy Leadership Team Quietly Reframing Its Value‑Based Care Ambitions?
Simply Wall St.  ·  01-10
Is Oncology Institute’s (TOI) New Tech‑Heavy Leadership Team Quietly Reframing Its Value‑Based Care Ambitions?
Oncology Institute promotes Panda to CIO, Mariano to CPO
TIPRANKS  ·  01-09
Oncology Institute promotes Panda to CIO, Mariano to CPO

Introduction

Company Name.
The Oncology Institute
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates in three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient blood product transfusions, and patient support services. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Issue price:
--